Permselective dysfunction of podocyte-podocyte contact upon angiotensin II unravels the molecular target for renoprotective intervention.
about
Key fibrogenic mediators: old players. Renin–angiotensin systemEndothelin and the glomerulus in chronic kidney diseaseRestoration of podocyte structure and improvement of chronic renal disease in transgenic mice overexpressing renin.Angiotensin receptor blocker protection against podocyte-induced sclerosis is podocyte angiotensin II type 1 receptor-independent.Bradykinin decreases podocyte permeability through ADAM17-dependent epidermal growth factor receptor activation and zonula occludens-1 rearrangementMicroRNA-324-3p promotes renal fibrosis and is a target of ACE inhibitionEndothelin and the podocyteLipopolysaccharide induces inducible nitric oxide synthase-dependent podocyte dysfunction via a hypoxia-inducible factor 1α and cell division control protein 42 and Ras-related C3 botulinum toxin substrate 1 pathway.Renal Lipotoxicity-Associated Inflammation and Insulin Resistance Affects Actin Cytoskeleton Organization in PodocytesProteinuria: is it all in the foot?ARB protects podocytes from HIV-1 nephropathy independently of podocyte AT1.Amelioration of crescentic glomerulonephritis by RhoA kinase inhibitor, Fasudil, through podocyte protection and prevention of leukocyte migrationComplement-mediated dysfunction of glomerular filtration barrier accelerates progressive renal injury.Angiotensin II contributes to diabetic renal dysfunction in rodents and humans via Notch1/Snail pathwayLatest treatment strategies for membranous nephropathy.Angiotensin-converting enzyme 2 and the kidney.Aldosterone and progression of kidney disease.Angiotensin II increases glomerular permeability by β-arrestin mediated nephrin endocytosis.Interventions for chronic kidney disease in people with sickle cell disease.Clinicopathological characteristics of obesity-associated focal segmental glomerulosclerosis.Acute and sustained actions of hyperglycaemia on endothelial and glomerular barrier permeability.Renin-angiotensin system within the diabetic podocyte.Interventions for chronic kidney disease in people with sickle cell disease.Deficiency of the Angiotensinase Aminopeptidase A Increases Susceptibility to Glomerular Injury.Generation of functional podocytes from human induced pluripotent stem cells.The role of renin angiotensin system inhibition in kidney repair.Shigatoxin-induced endothelin-1 expression in cultured podocytes autocrinally mediates actin remodeling.Fluvastatin prevents podocyte injury in a murine model of HIV-associated nephropathy.Antiviral innate immunity disturbs podocyte cell function.Renoprotective effects of an angiotensin II receptor blocker in experimental model rats with hypertension and metabolic disorders.Angiotensin II activation of TRPC6 channels in rat podocytes requires generation of reactive oxygen species.Relationship between G proteins coupled receptors and tight junctions.Klotho May Ameliorate Proteinuria by Targeting TRPC6 Channels in Podocytes.Angiotensin II provokes podocyte injury in murine model of HIV-associated nephropathy
P2860
Q26796631-CAB2B0CC-BB2B-4219-84B9-500000FD6156Q26828634-36F002E3-5E96-4FC1-8CA3-D8180808BBF7Q33495583-6B5FE61D-CEBD-4556-BFF5-EE84922E7137Q33920991-36203CE9-5553-45C5-9F16-794F81A898A8Q34128805-6DE9C49F-9878-4649-9117-D8DF330A4828Q34347713-3B6DEA8C-7661-428F-A403-CDBC60CEC540Q35452282-0C39FDD2-CEF9-46D2-94A9-A6142F7DB68FQ35688862-0426BF57-104E-42E0-AFBA-C2EEF8FDA153Q35834459-DF79FEEE-2629-4057-A630-570D5AD8A791Q35916180-00EFCCE4-81F7-453F-AA4C-1E7B68B90D35Q36129864-82CBBF04-94A7-4359-B4DB-5FA83FAD5DCBQ36482195-EFA76462-7F8F-4011-8D22-AE11C613F217Q36677636-743669D6-8046-462F-B8FD-C608DD12AF37Q36989148-D29C47A9-057E-4838-ACB9-13854E113BDFQ37013035-933E58CF-A3BE-4D51-AF26-E05FB995150DQ37068454-3ADDBA0A-E52F-485B-B0E5-8E30F8F0963AQ37378291-83B89F31-EAA4-4DE6-A52D-F9E167BB8176Q37526033-8B7328D7-2EC1-46D0-8431-B5B7984F22B5Q37713880-F7AE632E-E902-40B9-A4D3-1CED7E190F4AQ37886981-03209D1A-5153-477F-8AC5-C4DE51B94ACFQ37910988-0388F545-4760-428E-883F-F905C4CF1BE3Q38262105-1623F184-CC66-4CA3-91CE-1BBF4A5D2D47Q38696578-0F0F7A15-90D0-477C-A30F-193D52E76C0FQ38959449-B1741385-6809-42DD-B8D1-32A48CA1B18FQ41002198-0C36864F-71DD-46AB-BE47-2ED6FE51095EQ41206891-187983A6-FC44-4632-B9E3-7AE5B8DCD15EQ41837398-940A33CD-05F8-4F35-97CD-3DE206831BB7Q42448757-455F33E9-BE26-47A6-8740-F416293D2E60Q43072851-6CB930D9-46D7-431F-BAF8-A42742C46ECEQ43297018-0A25E7F9-10B1-46BB-B8F1-0CE3AC710FCBQ43552370-4372AB71-417C-4149-9359-BF75DA0D7F6EQ50116104-E2725762-1C0A-4D7E-881B-719C69D7D40CQ50235923-1DBC0725-E7EF-4833-9426-1CE1FA7A82E2Q57691243-A881DB83-F76F-4F16-8C79-3A4ED600F2DB
P2860
Permselective dysfunction of podocyte-podocyte contact upon angiotensin II unravels the molecular target for renoprotective intervention.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Permselective dysfunction of p ...... r renoprotective intervention.
@en
type
label
Permselective dysfunction of p ...... r renoprotective intervention.
@en
prefLabel
Permselective dysfunction of p ...... r renoprotective intervention.
@en
P2093
P2860
P50
P1476
Permselective dysfunction of p ...... r renoprotective intervention.
@en
P2093
Daniela Macconi
Maria Bonomelli
Marilena Mister
Marina Morigi
Mauro Abbate
Peter Mundel
Simona Buelli
Stefania Angioletti
P2860
P304
P356
10.2353/AJPATH.2006.050701
P407
P577
2006-04-01T00:00:00Z